The Central Defense Response Headquarters announced today (29th) that it will apply to the Ministry of Food and Drug Safety for an extraordinary income of 'Remdesivir', which is expected to be a treatment for Corona 19.

Special income is a system that allows drugs to be imported from abroad without prior notice in a national emergency.

"The central clinical committee evaluated that Remedyvir is safe and effective in the treatment of Corona19 pneumonia, and suggested that it agreed medically with the need to introduce Remedyvir in the absence of an alternative antiviral agent," said Jung Eun-kyung, general manager Explained the background of the income decision.

Remedyvir is a drug that was developed by Gilead Sciences, a US pharmaceutical company that developed the flu drug Tamiflu, as another treatment for the epidemic, Ebola.